Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis.
Mod Rheumatol. 2009;19(4):372-8 Authors: Kageyama Y, Kobayashi H, Kato N, Shimazu M This study was performed to analyze the effect of etanercept, the soluble tumor necrosis factor-alpha (TNF-alpha) receptor, on the serum levels of several chemokines including monocyte chemotactic protein-1 (MCP-1), regulated upon activation normal T expressed and presumably secreted (RANTES), and granzyme B in…